Category: Pancreatic Cancer
Clinical study for Advanced Pancreas Cancer treated by Oncothermia
Clinical study for Advanced Pancreas Cancer treated by Oncothermia Probability of survival Contact Us Summary Presented are clinical studies of pancreas cancer (PCA), an aggressive and common tumour. The studies took place in two centers and both made the treatments by oncothermia combined with the conventional therapies. The final results show an exceptional survival benefit […]
WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer
WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer PS Values Contact Us Summary Wilms’ tumor 1 (WT1) is a tumor-linked antigen highly expressed in cancer. We examined the safety of WT1-peptide pulsed dendritic cell (WT1-DC) vaccine in combination with chemotherapy in patients with surgically resected pancreatic cancer. immunotherapy has been put forward […]
Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer
Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer Contact Us Summary The goal of this study was to discover the therapeutic effects of adoptive immunotherapy following dendritic cell (DC) vaccine and cytokine-induced killer (CIK) cell therapy and evaluate its cytotoxicity, survival benefits and quality of […]
Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes
Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes Contact Us Summary This study aims to determine the clinical efficacy of immunotherapy using both dendritic cells pulsed with MUC1 peptide (MUC1-DC) and, cytotoxic T lymphocyte (CTL) sensitized with a pancreatic cancer. The results suggest that adoptive immunotherapy with MUC1-DC and […]
Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients Contact Us Summary The aim of this study is to compare the results of CHT alone against CHT in combination with mEHT for the treatment of stage III and IV pancreatic cancer. According to the findings, adding mEHT […]
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer Contact Us Summary Advanced pancreatic cancer (PC) has very poor prognosis with present treatments, thus necessitating continued efforts to find improved therapeutic approaches. Both preclinical and preliminary clinical data indicate that cytokine- induced killer (CIK) cells are an effective tool against various types […]
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers Contact Us Summary This study investigates the correlation of cytokines produced by Dendritic Cells with clinical outcomes in patients with diverse cancers. The results reveal, aDC injections were feasible and safe. Increased production of specific cytokines was correlated with […]
Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients
Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients Contact Us Summary This study monitors the efficacy and safety of Modulated electro-hyperthermia (mEHT) for the treatment of advanced pancreatic cancer. Pancreatic adenocarcinoma has a poor prognosis, resulting in a <10% survival rate at 5 years;However, The result suggests, mEHT […]
Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer
Vaccination with poly(IC:LC) and peptide-pulsed autologous Dendritic cells in Patients with Pancreatic Cancer Contact Us Summary This study investigates, DC-based immunotherapy, in conjunction with toll-like receptor (TLR)-3 agonist poly-ICLC, as a promising approach for harnessing immunity against metastatic or locally advanced unresectable pancreatic cancer (PC). As a result, the treatment was well-tolerated, with the most […]
Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study
Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study Contact Us Summary This study investigates the effects of Electro-hyperthermia on patients with pancreatic ductal adenocarcinoma (PDAC), supporting the perspectives with the improvements of the treatment possibilities. A trend in favor of mEHT was found in overall survival. mEHT treatment […]
